Security key
89455T109
TREACE MEDICAL CONCEPTS, INC. - Common Stock (TMCI)
CUSIP: 89455T109
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 37,892,233
- Total 13F value
- $314,933,438
- Share change
- +732,950
- Put/Call ratio
- 7.6%
- SEC-reported price per share
- $8.39
- Number of holders
- 136
- Value change
- +$6,396,329
- Number of buys
- 67
- Number of sells
- 68
- Shares outstanding
- 63,954,667
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
136
Top holders
10
TMCI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
TREACE MEDICAL CONCEPTS, INC. SEC filings
TREACE MEDICAL CONCEPTS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89455T109
Recent filing periods:
Ownership snapshot
Top reported holders of TMCI - TREACE MEDICAL CONCEPTS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
13D/G
Lead comparable stake: 3.4%
13D/G row: MORGAN STANLEY
Showing 1-6 of 15 holder rows.
Quick read
MORGAN STANLEY leads the comparable SEC ownership view at 3.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Comparable ownership
Top 5
MORGAN STANLEY
3.4%
ARMISTICE CAPITAL, LLC
9.7%
BlackRock, Inc.
5.9%
WILLIAM BLAIR INVESTMENT MANAGEME...
4.6%
VANGUARD GROUP INC
4.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
13D/G
Company
|
3.4%
from 13D/G
|
$15,932,506
2,141,466 shares
|
— | 31 Dec 2024 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
9.7%
|
$46,194,960
6,209,000 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
5.9%
|
$28,079,290
3,774,098 shares
|
— | 31 Dec 2024 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
Company
|
4.6%
|
$21,865,029
2,938,848 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
4.3%
|
$20,330,432
2,732,585 shares
|
— | 31 Dec 2024 |
| JPMORGAN CHASE & CO |
13F
Company
|
3.1%
|
$14,710,509
1,977,219 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
136
Shares
37,892,233
Rows available
136
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q3 2025 Across Filers
Q3 2025 holders
117
Q1 2025 holders
136
Holder diff
19
| Investor | Q3 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend